Allogene Therapeutics Announces Q2 Investor Conference Participation

Go back to Allogene Therapeutics Announces Q2 Investor Conference Participation
(NASDAQ: ALLO) Delayed: 1.50 -0.04 (2.6%)
Previous Close $1.54    52 Week High $ 
Open $1.57    52 Week Low $ 
Day High $1.58    P/E N/A 
Day Low $1.50    EPS $ 
Volume 4,632,604